Skip to Content Skip to Content

Perelman School of Medicine

Visit the School's Site
Reset All Filters
2696 Results
Penn Medicine Analysis Shows that One-Third of Americans Do Not Have Access to Stroke Center Within One Hour

Penn Medicine Analysis Shows that One-Third of Americans Do Not Have Access to Stroke Center Within One Hour

Stroke is one of the leading causes of death and disability in the United States, but access to rapid EMS care and appropriate stroke care centers with the ability to deliver acute stroke therapies can drastically mitigate the debilitating effects of a stroke. A population-based approach to health planning would prevent disparities in access to specialized stroke care, says new Penn Medicine research.

Lee-Ann Donegan

Penn Medicine: Gorilla Origins of the Last Two AIDS Virus Lineages Confirmed

Penn Medicine: Gorilla Origins of the Last Two AIDS Virus Lineages Confirmed

Two of the four known groups of human AIDS viruses (HIV-1 groups O and P) have originated in western lowland gorillas, according to an international team of scientists from the Perelman School of Medicine at the University of Pennsylvania, the University of Montpellier, the University of Edinburgh, and others.

Karen Kreeger

Twitter Chatter Predicts Health Insurance Marketplace Enrollment, Penn Study Shows

Twitter Chatter Predicts Health Insurance Marketplace Enrollment, Penn Study Shows

An increase in Twitter sentiment (the positivity or negativity of tweets) is associated with an increase in state-level enrollment in the Affordable Care Act’s (ACA) health insurance marketplaces — a phenomenon that points to use of the social media platform as a real-time gauge of public opinion and provides a way for marketplaces to quickly identify enrollment changes and emerging issues.

Anna Duerr

Prescription Drug-Induced Liver Failure is Uncommon; Over-the-Counter Medications and Dietary/Herbal Supplements are Most Common Causes, Penn Study Finds

Prescription Drug-Induced Liver Failure is Uncommon; Over-the-Counter Medications and Dietary/Herbal Supplements are Most Common Causes, Penn Study Finds

Drug-induced acute liver failure is uncommon, and over-the-counter medications and dietary and herbal supplements -- not prescription drugs -- are its most common causes, according to new research from the Perelman School of Medicine at the University of Pennsylvania. The findings are published in the current issue of Gastroenterology.

Lee-Ann Donegan

Successful Cognitive Behavioral Therapy in Youth Leads to Decreased Thinking about Suicide, Penn Medicine Study Finds

Successful Cognitive Behavioral Therapy in Youth Leads to Decreased Thinking about Suicide, Penn Medicine Study Finds

Penn Medicine researchers found that patients who did not respond to cognitive behavioral therapy (CBT) for anxiety in childhood had more chronic and enduring patterns of suicidal ideation at 7 to 19 years after treatment. This study adds to the literature that suggests that successful CBT for childhood anxiety confers long-term benefits. The complete study is available in the Journal of the American Academy of Child & Adolescent Psychiatry.

Lee-Ann Donegan

Penn Medicine Physician Finds No Preventive Benefits for Widely Used Kidney Cancer Drugs

Penn Medicine Physician Finds No Preventive Benefits for Widely Used Kidney Cancer Drugs

Two widely used targeted therapy drugs— approved by the FDA for use in metastatic kidney cancer —are no more effective than a placebo in preventing return of the disease to increase life spans of patients suffering from advanced kidney cancer after surgery, according to new results to be presented by a researcher at the University of Pennsylvania’s 

Steve Graff

Eczema Medication Unlikely to Increase Risk of Cancer in Children, Penn Team Finds

Eczema Medication Unlikely to Increase Risk of Cancer in Children, Penn Team Finds

The topical eczema medicine pimecrolimus appears unlikely to be associated with an increased risk of cancer in children, based on a group of children who were followed for 10 years, according to study published online this week in JAMA Dermatology.

Karen Kreeger

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Penn Medicine Study Describes Development of Personalized Cellular Therapy for Brain Cancer

Immune cells engineered to seek out and attack a type of deadly brain cancer were found to be both safe and effective at controlling tumor growth in mice that were treated with these modified cells, according to a study published in Science Translational Medicine by a team from the Perelman School of Medicine at the University of Pennsy

Holly Auer